<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02814240</url>
  </required_header>
  <id_info>
    <org_study_id>PETIT NOVARTIS 2014</org_study_id>
    <nct_id>NCT02814240</nct_id>
  </id_info>
  <brief_title>Hepatic Steatosis and Pituitary Gland Failure, Evaluation by Nuclear Magnetic Resonance (NMR) Imaging</brief_title>
  <acronym>SHAH</acronym>
  <official_title>Hepatic Steatosis and Pituitary Gland Failure, Evaluation by NMR Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      The investigator put forward the hypothesis that liver fat mass in patients with pituitary
      gland failure is greater than that in a control population. Failure of the anterior pituitary
      and more particularly impaired production of growth hormone (GH) could be the principal
      mechanism responsible for increased liver fat mass in these patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of liver fat mass by Magnetic Resonance Imaging (MRI)</measure>
    <time_frame>Measured at Day 0</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">166</enrollment>
  <condition>Hepatic Steatosis</condition>
  <condition>Pituitary Gland Failure</condition>
  <arm_group>
    <arm_group_label>Pituitary gland failure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NMR</intervention_name>
    <arm_group_label>Pituitary gland failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood samples</intervention_name>
    <arm_group_label>Pituitary gland failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>fibroscan</intervention_name>
    <arm_group_label>Pituitary gland failure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have provided consent

          -  Patients over 18 years

          -  Patients with pituitary disease (Pituitary adenoma, anterior pituitary failure,
             craniopharyngioma, empty sella syndrome, hypophysitis, infiltration of the stalk)
             requiring Magnetic Resonance Imaging (MRI) of the pituitary.

        Exclusion Criteria:

          -  Persons without national health insurance

          -  Pacemaker (Contra-Indication for MRI)

          -  Alcohol consumption greater than 4 glasses a day

          -  Any treatment able to increase liver fat content (glitazones, systemic corticoids,
             immunosuppressants) are forbidden

          -  Presence of metallic implants (Contra-Indication for MRI)

          -  Claustrophobia

          -  Adult under guardianship

          -  Pregnant or breast-feeding women

          -  Patients with a liver disease other than non-alcoholic steatosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-Michel PETIT</last_name>
    <phone>03.80.29.34.53</phone>
    <phone_ext>33</phone_ext>
    <email>jean-michel.petit@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Michel PETIT</last_name>
      <phone>3.80.29.34.53</phone>
      <phone_ext>33</phone_ext>
      <email>jean-michel.petit@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2016</study_first_submitted>
  <study_first_submitted_qc>June 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2016</study_first_posted>
  <last_update_submitted>June 24, 2016</last_update_submitted>
  <last_update_submitted_qc>June 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pituitary Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

